The results of immunotherapy in patients with recurrent and metastatic human papilloma virus positive head and neck squamous cell carcinoma
Human papilloma virus (HPV), primarily type 16 (less commonly type 18), is associated with oropharyngeal squamous cell carcinoma (OPSCC). According to literature data, between 25 and 70 % of all cases of this cancer are linked to HPV infection. In the USA and some countries of the European Union, HP...
Saved in:
Main Authors: | A. V. Ignatova, Yu. V. Alymov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2024-06-01
|
Series: | Опухоли головы и шеи |
Subjects: | |
Online Access: | https://ogsh.abvpress.ru/jour/article/view/967 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pembrolizumab in treatment of head and neck squamous cell carcinoma: clinical cases and real-world practice
by: Yu. V. Alymov, et al.
Published: (2023-09-01) -
NEW OPPORTUNITIES FOR IMMUNE THERAPY IN PATIENTS WITH DISSEMINATED RECURRENT SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
by: A. M. Mudunov, et al.
Published: (2017-06-01) -
Successful treatment of recurrent unresectable squamous cell carcinoma of the head and neck using pembrolizumab
by: A. M. Mudunov, et al.
Published: (2019-04-01) -
An update on head and neck squamous cell carcinoma in respect to classification and systemic therapy. Extended review
by: A. Mudunov, et al.
Published: (2018-04-01) -
Estimation of the prevalence of HPV-positive squamous cell carcinoma of the oropharynx on the example of a separate sample in the Russian Federation
by: B. G. Pkheshkhova, et al.
Published: (2022-04-01)